1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Aptámeros

Aptámeros

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Pinto-Diez, Celia, Ferreras-Martin, Raquel, Carrion-Marchante, Rebeca, Gonzalez, Victor M., Martín ME.

    Deeping in the Role of the MAP-Kinases Interacting Kinases (MNKs) in Cancer

    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES . 21(8): . Nº de citas: 15

    [doi:10.3390/ijms21082967]

  • Solana JC, Ramirez, Laura, Cook, Emma C. L., Hernandez-Garcia, Elena, Sacristan, Silvia, Martín ME, Manuel Gonzalez, Victor, Reguera RM, Balaña-Fouce R, Fresno, Manuel, Requena JM, Iborra, Salvador, Soto, Manuel.

    Subcutaneous Immunization of Leishmania HSP70-II Null Mutant Line Reduces the Severity of the Experimental Visceral Leishmaniasis in BALB/c Mice

    Vaccines . 8(1): . Nº de citas: 11

    [doi:10.3390/vaccines8010141]

  • Vera-Puente O, Rodriguez-Antolin C, Salgado-Figueroa A, Michalska P, Pernia O, Reid BM, Rosas R, Garcia-Guede A, SacristÁn S, Jimenez J, Esteban-Rodriguez I, Martin ME, Sellers TA, León R, Gonzalez VM, De Castro J, Ibanez de Caceres I.

    MAFG is a potential therapeutic target to restore chemosensitivity in cisplatin-resistant cancer cells by increasing reactive oxygen species.

    TRANSLATIONAL RESEARCH . 200: 1-17. Nº de citas: 17

    [doi:10.1016/j.trsl.2018.06.005]

  • Fernández G, Moraga A, Cuartero MI, García-Culebras A, Peña-Martínez C, Pradillo JM, Hernández-Jiménez M, Sacristán S, Ayuso MI, Gonzalo-Gobernado R, Fernández-López D, Martín ME, Moro MA, González VM, Lizasoain I.

    TLR4-Binding DNA Aptamers Show a Protective Effect against Acute Stroke in Animal Models.

    MOLECULAR THERAPY . 26(8): 2047-2059. Nº de citas: 19

    [doi:10.1016/j.ymthe.2018.05.019]

  • Chonco L, Fernández G, Kalhapure R, Hernáiz MJ, García-Oliva C, Gonzalez VM, Martín ME, Govender T, Parboosing R.

    Novel DNA Aptamers Against CCL21 Protein: Characterization and Biomedical Applications for Targeted Drug Delivery to T Cell-Rich Zones.

    NUCLEIC ACID THERAPEUTICS . 28(4): 242-251. Nº de citas: 5

    [doi:10.1089/nat.2017.0689]

  • Garde E, Ramírez L, Corvo L, Solana JC, Martín ME, González VM, Gómez-Nieto C, Barral A, Barral-Netto M, Requena JM, Iborra S, Soto M.

    Analysis of the Antigenic and Prophylactic Properties of the Leishmania Translation Initiation Factors eIF2 and eIF2B in Natural and Experimental Leishmaniasis.

    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY . 8: 112-112. Nº de citas: 6

    [doi:10.3389/fcimb.2018.00112]

  • Pinto-Díez C, García-Recio EM, Pérez-Morgado MI, García-Hernández M, Sanz-Criado L, Sacristán S, Toledo-Lobo MV, Pérez-Mies B, Esteban-Rodríguez I, Pascual A, Garcia-Villanueva M, Martínez-Jañez N, González VM, Martín ME.

    Increased expression of MNK1b, the spliced isoform of MNK1, predicts poor prognosis and is associated with triple-negative breast cancer.

    Oncotarget . 9(17): 13501-13516.

    [doi:10.18632/oncotarget.24417]

  • Sanmartín-Salinas P, Toledo-Lobo MV, Noguerales-Fraguas F, Fernández-Contreras ME, Guijarro LG.

    Overexpression of insulin receptor substrate-4 is correlated with clinical staging in colorectal cancer patients.

    JOURNAL OF MOLECULAR HISTOLOGY . 49(1): 39-49. Nº de citas: 10

    [doi:10.1007/s10735-017-9745-0]

  • Moreno E, Schwartz J, Calvo A, Blanco L, Larrea E, Irache JM, Sanmartín C, Coulman SA, Soto M, Birchall JC, Espuelas S.

    Skin vaccination using microneedles coated with a plasmid DNA cocktail encoding nucleosomal histones of Leishmania spp.

    INTERNATIONAL JOURNAL OF PHARMACEUTICS . 533(1): 236-244. Nº de citas: 19

    [doi:10.1016/j.ijpharm.2017.09.055]

  • Casado S, Lobo MDVT, Paíno CL.

    Dynamics of plasma membrane surface related to the release of extracellular vesicles by mesenchymal stem cells in culture.

    SCIENTIFIC REPORTS . 7(1): 6767-6767. Nº de citas: 23

    [doi:10.1038/s41598-017-07265-x]

  • Solana JC, Ramírez L, Corvo L, de Oliveira CI, Barral-Netto M, Requena JM, Iborra S, Soto M.

    Vaccination with a Leishmania infantum HSP70-II null mutant confers long-term protective immunity against Leishmania major infection in two mice models.

    PLOS NEGLECTED TROPICAL DISEASES . 11(5): . Nº de citas: 16

    [doi:10.1371/journal.pntd.0005644]

  • Martins VT, Lage DP, Duarte MC, Carvalho AM, Costa LE, Mendes TA, Vale DL, Menezes-Souza D, Roatt BM, Tavares CA, Soto M, Coelho EA.

    A recombinant fusion protein displaying murine and human MHC class I- and II-specific epitopes protects against Leishmania amazonensis infection.

    CELLULAR IMMUNOLOGY . 313: 32-42. Nº de citas: 13

    [doi:10.1016/j.cellimm.2016.12.008]

  • Román ID, Cano-Martínez D, Lobo MV, Fernández-Moreno MD, Hernández-Breijo B, Sacristán S, Sanmartín-Salinas P, Monserrat J, Gisbert JP, Guijarro LG.

    Infliximab therapy reverses the increase of allograft inflammatory factor-1 in serum and colonic mucosa of rats with inflammatory bowel disease.

    Biomarkers . 22(2): 133-144. Nº de citas: 14

    [doi:10.1080/1354750X.2016.1252950]

  • Vaz Salgado MA, Soto M, Reguero ME, Muñoz G, Cabañero A, Gallego I, Resano S, Longo F, Madariaga A, Gomez A, Carrato A.

    Clinical behavior of solitary fibrous tumor: a retrospective review of 30 patients.

    CLINICAL & TRANSLATIONAL ONCOLOGY . 19(3): 357-363. Nº de citas: 7

    [doi:10.1007/s12094-016-1536-7]

  • Martins VT, Duarte MC, Lage DP, Costa LE, Carvalho AM, Mendes TA, Roatt BM, Menezes-Souza D, Soto M, Coelho EA.

    A recombinant chimeric protein composed of human and mice-specific CD4(+) and CD8(+) T-cell epitopes protects against visceral leishmaniasis.

    PARASITE IMMUNOLOGY . 39(1): . Nº de citas: 30

    [doi:10.1111/pim.12359]

  • González VM, Martín ME, Fernández G, García-Sacristán A.

    Use of Aptamers as Diagnostics Tools and Antiviral Agents for Human Viruses.

    PHARMACEUTICALS . 9(4): . Nº de citas: 45

    [doi:10.3390/ph9040078]

  • Iborra S, Martínez-López M, Cueto FJ, Conde-Garrosa R, Del Fresno C, Izquierdo HM, Abram CL, Mori D, Campos-Martín Y, Reguera RM, Kemp B, Yamasaki S, Robinson MJ, Soto M, Lowell CA, Sancho D.

    Leishmania Uses Mincle to Target an Inhibitory ITAM Signaling Pathway in Dendritic Cells that Dampens Adaptive Immunity to Infection

    Immunity . 45(4): 788-801. Nº de citas: 58

    [doi:10.1016/j.immuni.2016.09.012]

  • Genes CM, de Lucio H, González VM, Sánchez-Murcia PA, Rico E, Gago F, Fasel N, Jiménez-Ruiz A.

    A functional BH3 domain in an aquaporin from Leishmania infantum.

    Cell death discovery . 2: 16043-16043.

    [doi:10.1038/cddiscovery.2016.43]